Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2427576rdf:typepubmed:Citationlld:pubmed
pubmed-article:2427576lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2427576lifeskim:mentionsumls-concept:C1171362lld:lifeskim
pubmed-article:2427576lifeskim:mentionsumls-concept:C0021644lld:lifeskim
pubmed-article:2427576lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:2427576lifeskim:mentionsumls-concept:C1515670lld:lifeskim
pubmed-article:2427576lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:2427576pubmed:issue5lld:pubmed
pubmed-article:2427576pubmed:dateCreated1986-9-26lld:pubmed
pubmed-article:2427576pubmed:abstractTextInsulin-treated diabetics develop a heterogeneous antibody response to the protein hormone. To understand the repertoire of this diverse immune response, we developed monoclonal antibodies (Mab) that recognize idiotypic determinants on anti-insulin antibodies. Two Mab that recognize distinct idiotopes on anti-insulin antibodies were studied in detail. These idiotopes were present on IgG, but not IgM, anti-insulin antibodies from the proband and from four of 11 insulin-treated diabetics. The determinants recognized were distinct from conventional allotype (Gm) markers and were found in both Type I and Type II diabetics. The partial inhibition of anti-idiotope binding by beef insulin suggests that idiotopes related to the binding site for beef insulin may be recognized. When the presence of idiotope-positive molecules was determined sequentially during insulin therapy, in one patient, idiotope expression was found to be cyclical. In contrast, the total amount of anti-insulin antibody was constant, whereas idiotope expression varied. These data suggest that common V region determinants are employed in the anti-insulin response, and their variable expression may reflect dynamic regulation during chronic insulin therapy.lld:pubmed
pubmed-article:2427576pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2427576pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2427576pubmed:languageenglld:pubmed
pubmed-article:2427576pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2427576pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2427576pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2427576pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2427576pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2427576pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2427576pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2427576pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2427576pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2427576pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2427576pubmed:statusMEDLINElld:pubmed
pubmed-article:2427576pubmed:monthSeplld:pubmed
pubmed-article:2427576pubmed:issn0022-1767lld:pubmed
pubmed-article:2427576pubmed:authorpubmed-author:ThomasJ WJWlld:pubmed
pubmed-article:2427576pubmed:authorpubmed-author:NellL JLJlld:pubmed
pubmed-article:2427576pubmed:authorpubmed-author:VirtaV JVJlld:pubmed
pubmed-article:2427576pubmed:issnTypePrintlld:pubmed
pubmed-article:2427576pubmed:day1lld:pubmed
pubmed-article:2427576pubmed:volume137lld:pubmed
pubmed-article:2427576pubmed:ownerNLMlld:pubmed
pubmed-article:2427576pubmed:authorsCompleteYlld:pubmed
pubmed-article:2427576pubmed:pagination1610-5lld:pubmed
pubmed-article:2427576pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:2427576pubmed:meshHeadingpubmed-meshheading:2427576-...lld:pubmed
pubmed-article:2427576pubmed:meshHeadingpubmed-meshheading:2427576-...lld:pubmed
pubmed-article:2427576pubmed:meshHeadingpubmed-meshheading:2427576-...lld:pubmed
pubmed-article:2427576pubmed:meshHeadingpubmed-meshheading:2427576-...lld:pubmed
pubmed-article:2427576pubmed:meshHeadingpubmed-meshheading:2427576-...lld:pubmed
pubmed-article:2427576pubmed:meshHeadingpubmed-meshheading:2427576-...lld:pubmed
pubmed-article:2427576pubmed:meshHeadingpubmed-meshheading:2427576-...lld:pubmed
pubmed-article:2427576pubmed:meshHeadingpubmed-meshheading:2427576-...lld:pubmed
pubmed-article:2427576pubmed:meshHeadingpubmed-meshheading:2427576-...lld:pubmed
pubmed-article:2427576pubmed:meshHeadingpubmed-meshheading:2427576-...lld:pubmed
pubmed-article:2427576pubmed:meshHeadingpubmed-meshheading:2427576-...lld:pubmed
pubmed-article:2427576pubmed:meshHeadingpubmed-meshheading:2427576-...lld:pubmed
pubmed-article:2427576pubmed:meshHeadingpubmed-meshheading:2427576-...lld:pubmed
pubmed-article:2427576pubmed:meshHeadingpubmed-meshheading:2427576-...lld:pubmed
pubmed-article:2427576pubmed:meshHeadingpubmed-meshheading:2427576-...lld:pubmed
pubmed-article:2427576pubmed:meshHeadingpubmed-meshheading:2427576-...lld:pubmed
pubmed-article:2427576pubmed:year1986lld:pubmed
pubmed-article:2427576pubmed:articleTitleIdiotypic determinants on human anti-insulin antibodies are cyclically expressed.lld:pubmed
pubmed-article:2427576pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2427576pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2427576lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2427576lld:pubmed